These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 2263618)

  • 21. Activity of linked HIV-1 proteinase dimers containing mutations in the active site region.
    Bagossi P; Cheng YS; Oroszlan S; Tözsér J
    Protein Eng; 1996 Nov; 9(11):997-1003. PubMed ID: 8961352
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kinetic studies of human immunodeficiency virus type 1 protease and its active-site hydrogen bond mutant A28S.
    Ido E; Han HP; Kezdy FJ; Tang J
    J Biol Chem; 1991 Dec; 266(36):24359-66. PubMed ID: 1761538
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kinetic, stability, and structural changes in high-resolution crystal structures of HIV-1 protease with drug-resistant mutations L24I, I50V, and G73S.
    Liu F; Boross PI; Wang YF; Tozser J; Louis JM; Harrison RW; Weber IT
    J Mol Biol; 2005 Dec; 354(4):789-800. PubMed ID: 16277992
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human immunodeficiency virus proteinase dimer as component of the viral polyprotein prevents particle assembly and viral infectivity.
    Kräusslich HG
    Proc Natl Acad Sci U S A; 1991 Apr; 88(8):3213-7. PubMed ID: 2014242
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An efficient procedure for the expression and purification of HIV-1 protease from inclusion bodies.
    Nguyen HL; Nguyen TT; Vu QT; Le HT; Pham Y; Trinh PL; Bui TP; Phan TN
    Protein Expr Purif; 2015 Dec; 116():59-65. PubMed ID: 26231073
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Altered gag polyprotein cleavage specificity of feline immunodeficiency virus/human immunodeficiency virus mutant proteases as demonstrated in a cell-based expression system.
    Lin YC; Brik A; de Parseval A; Tam K; Torbett BE; Wong CH; Elder JH
    J Virol; 2006 Aug; 80(16):7832-43. PubMed ID: 16873240
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autoprocessing of HIV-1 protease is tightly coupled to protein folding.
    Louis JM; Clore GM; Gronenborn AM
    Nat Struct Biol; 1999 Sep; 6(9):868-75. PubMed ID: 10467100
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An E. coli expression system which detoxifies the HIV protease.
    Korant BD; Rizzo CJ
    Biomed Biochim Acta; 1991; 50(4-6):643-6. PubMed ID: 1801736
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression and purification of active form of HIV-1 protease from E.coli.
    Wan M; Loh BN
    Biochem Mol Biol Int; 1995 Apr; 35(4):899-912. PubMed ID: 7627139
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Purification and characterization of naturally occurring HIV-1 (South African subtype C) protease mutants from inclusion bodies.
    Maseko SB; Natarajan S; Sharma V; Bhattacharyya N; Govender T; Sayed Y; Maguire GE; Lin J; Kruger HG
    Protein Expr Purif; 2016 Jun; 122():90-6. PubMed ID: 26917227
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of HIV protease activity by heterodimer formation.
    Babé LM; Pichuantes S; Craik CS
    Biochemistry; 1991 Jan; 30(1):106-11. PubMed ID: 1988010
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of mutations on the dimer stability and the pH optimum of the human foamy virus protease.
    Sperka T; Boross P; Eizert H; Tözsér J; Bagossi P
    Protein Eng Des Sel; 2006 Aug; 19(8):369-75. PubMed ID: 16799151
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isolation of mutants of human immunodeficiency virus protease based on the toxicity of the enzyme in Escherichia coli.
    Baum EZ; Bebernitz GA; Gluzman Y
    Proc Natl Acad Sci U S A; 1990 Jul; 87(14):5573-7. PubMed ID: 2196572
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interaction of mutant forms of the HIV-1 protease with substrate and inhibitors.
    Darke PL; Kohl NE; Hanobik MG; Leu CT; Vacca JP; Guare JP; Heimbach JC; Dixon RA
    Adv Exp Med Biol; 1991; 306():483-7. PubMed ID: 1812746
    [No Abstract]   [Full Text] [Related]  

  • 35. HIV-1 protease with leucine zipper fused at N-terminus exhibits enhanced linker amino acid-dependent activity.
    Yu FH; Wang CT
    Retrovirology; 2018 Apr; 15(1):32. PubMed ID: 29655366
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-level production of active HIV-1 protease in Escherichia coli.
    Rangwala SH; Finn RF; Smith CE; Berberich SA; Salsgiver WJ; Stallings WC; Glover GI; Olins PO
    Gene; 1992 Dec; 122(2):263-9. PubMed ID: 1487142
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A folding inhibitor of the HIV-1 protease.
    Broglia RA; Provasi D; Vasile F; Ottolina G; Longhi R; Tiana G
    Proteins; 2006 Mar; 62(4):928-33. PubMed ID: 16385559
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A transient precursor of the HIV-1 protease. Isolation, characterization, and kinetics of maturation.
    Wondrak EM; Nashed NT; Haber MT; Jerina DM; Louis JM
    J Biol Chem; 1996 Feb; 271(8):4477-81. PubMed ID: 8626801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug resistance mutations can effect dimer stability of HIV-1 protease at neutral pH.
    Xie D; Gulnik S; Gustchina E; Yu B; Shao W; Qoronfleh W; Nathan A; Erickson JW
    Protein Sci; 1999 Aug; 8(8):1702-7. PubMed ID: 10452615
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Programming the Rous sarcoma virus protease to cleave new substrate sequences.
    Ridky TW; Bizub-Bender D; Cameron CE; Weber IT; Wlodawer A; Copeland T; Skalka AM; Leis J
    J Biol Chem; 1996 May; 271(18):10538-44. PubMed ID: 8631853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.